Terms: = Ovarian cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA AND Diagnosis
31 results:
1. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
2. Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.
Kahn RM; Selenica P; Boerner T; Roche KL; Xiao Y; Sia TY; Maio A; Kemel Y; Sheehan M; Salo-Mullen E; Breen KE; Zhou Q; Iasonos A; Grisham RN; O'Cearbhaill RE; Chi DS; Berger MF; Kundra R; Schultz N; Ellenson LH; Stadler ZK; Offit K; Mandelker D; Aghajanian C; Zamarin D; Sabbatini P; Weigelt B; Liu YL
Gynecol Oncol; 2024 Jan; 180():35-43. PubMed ID: 38041901
[TBL] [Abstract] [Full Text] [Related]
3. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
[TBL] [Abstract] [Full Text] [Related]
4. Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers.
Mori T; Okamoto Y; Mu A; Ide Y; Yoshimura A; Senda N; Inagaki-Kawata Y; Kawashima M; Kitao H; Tokunaga E; Miyoshi Y; Ohsumi S; Tsugawa K; Ohta T; Katagiri T; Ohtsuru S; Koike K; Ogawa S; Toi M; Iwata H; Nakamura S; Matsuo K; Takata M
Cancer Med; 2023 Mar; 12(6):6594-6602. PubMed ID: 36345163
[TBL] [Abstract] [Full Text] [Related]
5. Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with fanca mutation: A case report.
Lai YH; Tung KC; Chen SC
Medicine (Baltimore); 2022 Sep; 101(39):e30719. PubMed ID: 36181052
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
Musacchio L; Califano D; Bartoletti M; Arenare L; Lorusso D; Losito NS; Cormio G; Greggi S; Raspagliesi F; Valabrega G; Salutari V; Pisano C; Spina A; Russo D; Del Sesto M; Canzonieri V; Ferraù F; Zannoni GF; Loizzi V; Ghizzoni V; Casanova C; Tuninetti V; Ducceschi M; Del Vecchio V; Scalone S; Priolo D; Perrone F; Scambia G; Pignata S
Br J Cancer; 2022 Nov; 127(8):1479-1486. PubMed ID: 35869143
[TBL] [Abstract] [Full Text] [Related]
7. MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous ovarian Carcinoma.
Manning-Geist B; Gordhandas S; Liu YL; Zhou Q; Iasonos A; Da Cruz Paula A; Mandelker D; Long Roche K; Zivanovic O; Maio A; Kemel Y; Chi DS; O'Cearbhaill RE; Aghajanian C; Weigelt B; Chui MH; Grisham RN
Clin Cancer Res; 2022 Oct; 28(20):4456-4465. PubMed ID: 35443055
[TBL] [Abstract] [Full Text] [Related]
8. Folic Acid-Modified Fluorescent-Magnetic Nanoparticles for Efficient Isolation and Identification of Circulating Tumor Cells in ovarian cancer.
Pan Y; Wang Z; Ma J; Zhou T; Wu Z; Ding P; Sun N; Liu L; Pei R; Zhu W
Biosensors (Basel); 2022 Mar; 12(3):. PubMed ID: 35323454
[TBL] [Abstract] [Full Text] [Related]
9. Fanconi-like anemia related to a FANCM mutation.
Encarnación JA; Cerezuela P; Español I; García MR; Manso C; De la Fuente I; Garrigós N; Viney A; Minguillon J; Surrallés J
Eur J Med Genet; 2022 Jan; 65(1):104399. PubMed ID: 34793962
[TBL] [Abstract] [Full Text] [Related]
10. Myositis autoantibodies in Iranian myositis patients: assessment the frequency and clinical relevancy.
Ebrahimi M; Rostamian A; Rafiei-Latianee R; Najafizadeh SR; Movaseghi S; Faezi ST; Ghazanfari T
Clin Rheumatol; 2022 Feb; 41(2):533-539. PubMed ID: 34514533
[TBL] [Abstract] [Full Text] [Related]
11. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
Ferrer-Avargues R; Castillejo MI; Dámaso E; Díez-Obrero V; Garrigos N; Molina T; Codoñer-Alejos A; Segura Á; Sánchez-Heras AB; Castillejo A; Soto JL
Cancer Commun (Lond); 2021 Mar; 41(3):218-228. PubMed ID: 33630411
[TBL] [Abstract] [Full Text] [Related]
12. Folic acid functionalized gold nanoclusters for enabling targeted fluorescence imaging of human ovarian cancer cells.
Hada AM; Craciun AM; Focsan M; Borlan R; Soritau O; Todea M; Astilean S
Talanta; 2021 Apr; 225():121960. PubMed ID: 33592715
[TBL] [Abstract] [Full Text] [Related]
13. Folic acid-functionalized magnetic nanoprobes via a PAMAM dendrimer/SA-biotin mediated cascade-amplifying system for the efficient enrichment of circulating tumor cells.
Meng X; Sun P; Xu H; Wang Z
Biomater Sci; 2020 Nov; 8(22):6395-6403. PubMed ID: 33034317
[TBL] [Abstract] [Full Text] [Related]
14. Targeting Glutathione and Cystathionine β-Synthase in ovarian cancer Treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation.
Santos I; Ramos C; Mendes C; Sequeira CO; Tomé CS; Fernandes DGH; Mota P; Pires RF; Urso D; Hipólito A; Antunes AMM; Vicente JB; Pereira SA; Bonifácio VDB; Nunes SC; Serpa J
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31635026
[TBL] [Abstract] [Full Text] [Related]
15. [Genetic analysis of Japanese patients with Fanconi anemia: novel findings].
Mori M; Yabe H; Yabe M; Takata M
Rinsho Ketsueki; 2019; 60(6):691-701. PubMed ID: 31281162
[TBL] [Abstract] [Full Text] [Related]
16. Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery.
Liu J; Xu F; Huang J; Xu J; Liu Y; Yao Y; Ao M; Li A; Hao L; Cao Y; Hu Z; Ran H; Wang Z; Li P
Biomater Sci; 2018 Nov; 6(11):2838-2849. PubMed ID: 30229771
[TBL] [Abstract] [Full Text] [Related]
17. A Systems Biology Approach to Understanding the Pathophysiology of High-Grade Serous ovarian cancer: Focus on Iron and Fatty Acid Metabolism.
Konstorum A; Lynch ML; Torti SV; Torti FM; Laubenbacher RC
OMICS; 2018 Jul; 22(7):502-513. PubMed ID: 30004845
[TBL] [Abstract] [Full Text] [Related]
18. In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.
Patel NR; Piroyan A; Ganta S; Morse AB; Candiloro KM; Solon AL; Nack AH; Galati CA; Bora C; Maglaty MA; O'Brien SW; Litwin S; Davis B; Connolly DC; Coleman TP
Cancer Biol Ther; 2018 Jul; 19(7):554-564. PubMed ID: 29737910
[TBL] [Abstract] [Full Text] [Related]
19. Folic Acid Targeting for Efficient Isolation and Detection of ovarian cancer CTCs from Human Whole Blood Based on Two-Step Binding Strategy.
Nie L; Li F; Huang X; Aguilar ZP; Wang YA; Xiong Y; Fu F; Xu H
ACS Appl Mater Interfaces; 2018 Apr; 10(16):14055-14062. PubMed ID: 29620849
[TBL] [Abstract] [Full Text] [Related]
20. Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.
Gupta S; Greenberg S; Grimmett J; Gaston D; Agarwal N; Lowrance W; Schiffman J; Kohlmann W
Fam Cancer; 2017 Oct; 16(4):545-550. PubMed ID: 28315974
[TBL] [Abstract] [Full Text] [Related]
[Next]
